Sleep Disorders 

  • Author: Roy H Lubit, MD, PhD; Chief Editor: Iqbal Ahmed, MBBS, FRCPsych (UK)   more...
 
Updated: Jan 9, 2012
 

Background

Sleep disorders are among the most common clinical problems encountered in medicine and psychiatry. Sleep problems can be primary or result from a variety of psychiatric and medical conditions. Inadequate or nonrestorative sleep can markedly impair a patient's quality of life.[1]

Primary sleep disorders result from an endogenous disturbance in sleep-wake generating or timing mechanisms, often complicated by behavioral conditioning. Primary sleep disorders are subdivided into parasomnias and dyssomnias. Parasomnias are unusual experiences or behaviors during sleep and include sleep terror disorder and sleepwalking (which occur during Stage 4 sleep) and nightmare disorder (which occurs during REM sleep). Dyssomnias are characterized by abnormalities in the amount, quality, or timing of sleep. These include primary insomnia and hypersomnia, narcolepsy, breathing-related sleep disorder (ie, sleep apnea), and circadian rhythm sleep disorder.

Assessing if a sleep disorder is primary or secondary is important. At times, assessing if anxiety and depression are causing sleep problems or if the anxiety and depression are secondary to a primary sleep problem is difficult. See Medscape's Anxiety Disorders and Depression Resource Centers.

Primary insomnia is the general term for difficulty in initiating or maintaining sleep. Because sleep requirements vary from individual to individual, insomnia is considered clinically significant when a patient perceives the loss of sleep as a problem. Insomnia may be characterized further as acute (transient) or chronic.

Next

Pathophysiology

Rapid eye movement and nonrapid eye movement

Sleep is divided into 2 categories, rapid eye movement (REM) and nonrapid eye movement (NREM). Each of these sleep states is associated with distinct central nervous system activity.

NREM sleep is further divided into 4 progressive categories, termed stages 1-4 sleep. The arousal threshold rises with each stage of sleep, with stage 4 (delta) being the sleep state from which a person is least able to be aroused, characterized by high-amplitude slow waves.

REM sleep is characterized by muscle atonia, episodic REMs, and low-amplitude fast waves on electroencephalogram (EEG) readings. Dreaming occurs mainly during REM sleep.

Disturbances in the pattern and periodicity of REM and NREM sleep are often found when people aver to experiencing sleep disorders.

Sleep-wake cycles

Sleep-wake cycles are governed by a complex group of biological processes that serve as internal clocks.

The suprachiasmatic nucleus, located in the hypothalamus, is thought to be the body's anatomic timekeeper, responsible for the release of melatonin on a 25-hour cycle.

The pineal gland secretes less melatonin when exposed to bright light; therefore, the level of this chemical is lowest during the daytime hours of wakefulness.

Multiple neurotransmitters are thought to play a role in sleep. These include serotonin from the dorsal raphe nucleus, norepinephrine contained in neurons with cell bodies in the locus ceruleus, and acetylcholine from the pontine reticular formation. Dopamine, on the other hand, is associated with wakefulness.

Abnormalities in the delicate balance of all of these chemical messenger systems may disrupt various physiologic, biologic, behavioral, and EEG parameters responsible for REM (ie, active) sleep and NREM (slow-wave) sleep.

Previous
Next

Epidemiology

Frequency

United States

Approximately one third of all Americans have sleep disorders at some point in their lives. Approximately 20-40% of adults report difficulty sleeping at some point each year. Approximately 17% of adults consider the problem to be serious. Sleep disorders are a common reason for patient visits throughout medicine. Approximately one third of adults have insufficient sleep syndrome. Twenty percent of adults report chronic insomnia.

Mortality/Morbidity

  • Chronic insomnia is associated with an increased risk of depression and accompanying danger of suicide, anxiety, excess disability, reduced quality of life, and increased use of health care resources.
  • Insufficient sleep can result in industrial and motor vehicle crashes, somatic symptoms, cognitive dysfunction, depression, and decrements in daytime work performance owing to fatigue or sleepiness.
  • Yaffe et al suggest that older women with sleep-disordered breathing (characterized by recurrent arousals from sleep and intermittent hypoxemia) have an increased risk of developing cognitive impairment compared with those without sleep-disordered breathing.[2]
  • One study suggests that among police officers in the United States and Canada, sleep disorders are common and are significantly associated with an increased risk of self-reported adverse outcomes in terms of health, performance, and safety.[3]

Sex

  • Primary insomnia is more common in women, with a female-to-male ratio of 3:2. Hormonal variations during the menstrual cycle or during menopause may cause disruptions in sleep.
  • Obstructive sleep apnea is more common in men (4%) than in women (2.5%).

Age

  • Increasing age predisposes to sleep disorders (5% in persons aged 30-50 y and 30% in those aged 50 y or older).
  • People who are elderly experience a decrease in total sleep time, with more frequent awakenings during the night.
  • People who are elderly have a higher incidence of general medical conditions and are more likely to be taking medications that cause sleep disruption.
  • People who are elderly may have widespread or multisite pain that is associated with sleep difficulty, according to the Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly study (MOBILIZE) study.[4]
Previous
 
 
Contributor Information and Disclosures
Author

Roy H Lubit, MD, PhD  Assistant Clinical Professor, Mount Sinai School of Medicine; Clinical Faculty, Department of Child Psychiatry, New York University School of Medicine; Private Practice

Disclosure: Nothing to disclose.

Coauthor(s)

Curley L Bonds II, MD  Associate Professor and Chair, Department of Psychiatry and Human Behavior, Charles Drew University of Medicine and Science; Clinical Professor, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, David Geffen School of Medicine

Curley L Bonds II, MD is a member of the following medical societies: American Medical Association and American Psychiatric Association

Disclosure: Nothing to disclose.

Michael A Lucia, MD, FAASM  Owner/CEO, Pulmonary, Allergy and Sleep Medicine, Sierra Pulmonary and Sleep Consultants, LLC

Michael A Lucia, MD, FAASM is a member of the following medical societies: American Academy of Sleep Medicine, American Association of Cardiovascular and Pulmonary Rehabilitation, and Nevada State Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Denis F Darko, MD  Executive Director, Clinical Research and Development, Global Neuroscience, AstraZeneca

Denis F Darko, MD is a member of the following medical societies: American College of Physicians and American Psychiatric Association

Disclosure: AstraZeneca Salary Management position

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Harold H Harsch, MD  Program Director of Geropsychiatry, Department of Geriatrics/Gerontology, Associate Professor, Department of Psychiatry and Department of Medicine, Froedtert Hospital, Medical College of Wisconsin

Harold H Harsch, MD is a member of the following medical societies: American Psychiatric Association

Disclosure: lilly Honoraria Speaking and teaching; Forest Labs None None; Pfizer Grant/research funds Speaking and teaching; Northstar None None; Novartis Grant/research funds research; Pfizer Honoraria Speaking and teaching; Sunovion Speaking and teaching; Otsuke Grant/research funds reseach; GlaxoSmithKline Grant/research funds research; Merck Honoraria Speaking and teaching

Chief Editor

Iqbal Ahmed, MBBS, FRCPsych (UK)  Faculty, Department of Psychiatry, Tripler Army Medical Center; Clinical Professor of Psychiatry, Clinical Professor of Geriatric Medicine, University of Hawaii, John A Burns School of Medicine

Iqbal Ahmed, MBBS, FRCPsych (UK) is a member of the following medical societies: Academy of Psychosomatic Medicine, American Association for Geriatric Psychiatry, American Neuropsychiatric Association, American Psychiatric Association, American Society of Clinical Psychopharmacology, and Royal College of Psychiatrists

Disclosure: Nothing to disclose.

References
  1. Zammit GK, Weiner J, Damato N, et al. Quality of life in people with insomnia. Sleep. May 1 1999;22 Suppl 2:S379-85. [Medline].

  2. Yaffe K, Laffan AM, Harrison SL, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA. Aug 10 2011;306(6):613-9. [Medline].

  3. Rajaratnam SM, Barger LK, Lockley SW, et al. Sleep disorders, health, and safety in police officers. JAMA. Dec 21 2011;306(23):2567-78. [Medline].

  4. Chen Q, Hayman LL, Shmerling RH, Bean JF, Leveille SG. Characteristics of Chronic Pain Associated with Sleep Difficulty in Older Adults: The Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly (MOBILIZE) Boston Study. J Am Geriatr Soc. Aug 2011;59(8):1385-92. [Medline].

  5. Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. May 20 2009;301(19):2005-15. [Medline].

  6. Elie R, Ruther E, Farr I, Salinas E. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group. J Clin Psychiatry. Aug 1999;60(8):536-44. [Medline].

  7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.

  8. Anders TF, Eiben LA. Pediatric sleep disorders: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. Jan 1997;36(1):9-20. [Medline].

  9. Benca RM, Ancoli-Israel S, Moldofsky H. Special considerations in insomnia diagnosis and management: depressed, elderly, and chronic pain populations. J Clin Psychiatry. 2004;65 Suppl 8:26-35. [Medline].

  10. Bryant PA, Trinder J, Curtis N. Sick and tired: Does sleep have a vital role in the immune system?. Nat Rev Immunol. Jun 2004;4(6):457-67. [Medline].

  11. Chen W, Kushida CA. Nasal obstruction in sleep-disordered breathing. Otolaryngol Clin North Am. Jun 2003;36(3):437-60. [Medline].

  12. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. JAMA. Sep 15 1989;262(11):1479-84. [Medline].

  13. Gillin JC, Byerley WF. Drug therapy: The diagnosis and management of insomnia. N Engl J Med. Jan 25 1990;322(4):239-48. [Medline].

  14. Hauri PJ, Hayes B, Sateia M, et al. Effectiveness of a sleep disorders center: a 9-month follow-up. Am J Psychiatry. May 1982;139(5):663-6. [Medline].

  15. Kaplan HI, Sadock BJ, Grebb JA. Normal sleep and sleep disorders. In: Kaplan and Sadock's Synopsis of Psychiatry. 7th ed. Baltimore, Md: Williams & Wilkins; 1994:699-716.

  16. Lamberg L. Promoting adequate sleep finds a place on the public health agenda. JAMA. May 26 2004;291(20):2415-7. [Medline].

  17. Lamberg L. Sleep-disordered breathing may spur behavioral, learning problems in children. JAMA. June 2007;27;297(24):2681-3. [Medline].

  18. Loewy DH, Black JE. Effective management of transient and chronic insomnia. In: CNS News. McMahon Publishing Group: New York, NY; 2000:19-22. [Full Text].

  19. No authors listed. Beauty sleep for the heart. Harv Heart Lett. May 2004;14(9):7. [Medline].

  20. Richert AC, Baran AS. A review of common sleep disorders. CNS Spectr. Feb 2003;8(2):102-9. [Medline].

  21. Schuen JN, Millard SL. Evaluation and treatment of sleep disorders in adolescents. Adolesc Med. Oct 2000;11(3):605-16. [Medline].

  22. Schwab RJ. Disturbances of sleep in the intensive care unit. Crit Care Clin. Oct 1994;10(4):681-94. [Medline].

  23. Veasey SC. Sedating, not treating sleep apnea: hit & run in primary care. J Clin Sleep Med. Oct 15 2005;1(4):372-3. [Medline].

  24. Zorner D, Geisler P. [Diagnostic Spectrum and Filtration Function of Outpatient Sleep Clinics]. Psychiatr Prax. May 2003;30(Suppl 2):173-175. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.